Literature DB >> 21645344

The role of lifestyle changes in the management of chronic liver disease.

Valerio Nobili1, Christine Carter-Kent, Ariel E Feldstein.   

Abstract

The prevalence of obesity worldwide has dramatically increased during the last three decades. With obesity comes a variety of adverse health outcomes which are grouped under the umbrella of metabolic syndrome. The liver in particular seems to be significantly impacted by fat deposition in the presence of obesity. In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis C virus and post-liver transplant status. The deleterious effects of obesity on liver disease and overall health can be significantly impacted by a culture that fosters sustained nutritional improvement and regular physical activity. Here we summarize the current evidence supporting non-pharmacological, lifestyle interventions that lead to weight reduction, improved physical activity and better nutrition as part of the management and treatment of these liver conditions.

Entities:  

Mesh:

Year:  2011        PMID: 21645344      PMCID: PMC3127780          DOI: 10.1186/1741-7015-9-70

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   8.775


  38 in total

1.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

Authors:  N N Zein; A S Abdulkarim; R H Wiesner; K S Egan; D H Persing
Journal:  J Hepatol       Date:  2000-02       Impact factor: 25.083

2.  Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention.

Authors:  Valerio Nobili; Anna Alisi; Massimiliano Raponi
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

3.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors:  L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

4.  Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score.

Authors:  Andrew L Samuelson; Maximilian Lee; Ahmad Kamal; Emmet B Keeffe; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

5.  Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.

Authors:  A Franzese; P Vajro; A Argenziano; A Puzziello; M P Iannucci; M C Saviano; F Brunetti; A Rubino
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.

Authors:  S H Mehta; F L Brancati; M S Sulkowski; S A Strathdee; M Szklo; D L Thomas
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

7.  Nutritional assessments of patients with non-alcoholic fatty liver disease.

Authors:  Chin Hee Kim; Jillian B Kallman; Chunhong Bai; Lisa Pawloski; Constance Gewa; Aimal Arsalla; Mary Ellen Sabatella; Zobair M Younossi
Journal:  Obes Surg       Date:  2008-06-17       Impact factor: 4.129

Review 8.  Posttransplant metabolic syndrome: an epidemic waiting to happen.

Authors:  Mangesh Pagadala; Srinivasan Dasarathy; Bijan Eghtesad; Arthur J McCullough
Journal:  Liver Transpl       Date:  2009-12       Impact factor: 5.799

9.  Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

Authors:  I J Hickman; A D Clouston; G A Macdonald; D M Purdie; J B Prins; S Ash; J R Jonsson; E E Powell
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff.

Authors:  Noriko Oza; Yuichiro Eguchi; Toshihiko Mizuta; Eriko Ishibashi; Yoichiro Kitajima; Hiroko Horie; Michiko Ushirogawa; Takeko Tsuzura; Shunya Nakashita; Hirokazu Takahashi; Yasunori Kawaguchi; Yasutomo Oda; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-09-01       Impact factor: 7.527

View more
  11 in total

Review 1.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

2.  Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of Differences Between Alcohol-Related and Non-Alcohol-Related Cirrhosis Candidates.

Authors:  Jan-Paul Gundlach; Felix Braun; Finn Mötter; Alexander Bernsmeier; Pablo Barrio; Nicola Ehmke; Rainer Günther; Holger Hinrichsen; Thomas Becker; Wolfgang Weinmann; Alexandra Schröck; Michel Yegles; Friedrich Martin Wurst
Journal:  Ann Transplant       Date:  2022-06-07       Impact factor: 1.479

3.  Knowledge, attitudes, and beliefs of patients with chronic liver disease.

Authors:  Brett Burnham; Sherrie Wallington; Irene A Jillson; Holta Trandafili; Kirti Shetty; Judy Wang; Christopher A Loffredo
Journal:  Am J Health Behav       Date:  2014-09

4.  Pharmacological effects of ginseng on liver functions and diseases: a minireview.

Authors:  Nguyen Huu Tung; Takuhiro Uto; Osamu Morinaga; Young Ho Kim; Yukihiro Shoyama
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-11       Impact factor: 2.629

5.  Dietary restriction, caloric value and the accumulation of hepatic fat.

Authors:  Leandro P Moura; Gabriella A Figueredo; Natália O Bertolini; Marilia Ceccato; Jessica R Pereira; Amanda Christine S Sponton; Maria Alice R de Mello
Journal:  Lipids Health Dis       Date:  2012-01-05       Impact factor: 3.876

6.  Improvement of BMI after Lifestyle Intervention Is Associated with Normalisation of Elevated ELF Score and Liver Stiffness in Obese Children.

Authors:  Imeke Goldschmidt; André Di Nanni; Carolin Streckenbach; Kerstin Schnell; Thomas Danne; Ulrich Baumann
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

Review 7.  The Complex Interactions Between Obesity, Metabolism and the Brain.

Authors:  Romina María Uranga; Jeffrey Neil Keller
Journal:  Front Neurosci       Date:  2019-05-24       Impact factor: 4.677

8.  Association of exercise participation levels with cardiometabolic health and quality of life in individuals with hepatitis C.

Authors:  Kate Hallsworth; Shion Gosrani; Sarah Hogg; Preya Patel; Aaron Wetten; Rachael Welton; Stuart McPherson; Matthew D Campbell
Journal:  BMJ Open Gastroenterol       Date:  2021-03

Review 9.  Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus.

Authors:  Lung-Wen Tsai; Yi-Hsiang Lu; Rajni Dubey; Jeng-Fong Chiou
Journal:  J Diabetes Res       Date:  2021-11-11       Impact factor: 4.011

10.  Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study.

Authors:  Daniel Pfirrmann; Yvonne Huber; Jörn Markus Schattenberg; Perikles Simon
Journal:  J Med Internet Res       Date:  2019-01-02       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.